Advax-adjuvanted Panblok-H7

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAdvax-adjuvanted Panblok-H7

Drug Alias NameAdvax-adjuvanted H7N9 avian influenza vaccine (Vaxine)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesVaxine Pty Ltd

China Registration ClassN/A

Develop Information

Active CompaniesVaxine Pty Ltd

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A